Application 076877
- Type
- ANDA
- Sponsor
- INVATECH
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | GABAPENTIN | GABAPENTIN | TABLET;ORAL | 600MG | No | No |
| 002 | GABAPENTIN | GABAPENTIN | TABLET;ORAL | 800MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A076877-001 | GABAPENTIN | GABAPENTIN | 600MG | TABLET / ORAL | 2006-07-06 | ||
| A076877-002 | GABAPENTIN | GABAPENTIN | 800MG | TABLET / ORAL | 2006-07-06 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A076877-001 | GABAPENTIN | 600MG | TABLET / ORAL | 2006-07-06 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | A076877-002 | GABAPENTIN | 800MG | TABLET / ORAL | 2006-07-06 | 84e616aacf4f… | ||
| 2026-08-18 06:07:40 | 2026-07 | A076877-001 | GABAPENTIN | 600MG | TABLET / ORAL | 2006-07-06 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | A076877-002 | GABAPENTIN | 800MG | TABLET / ORAL | 2006-07-06 | caaa826d4ba7… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A076877-001 | GABAPENTIN | 600MG | TABLET / ORAL | 2006-07-06 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A076877-002 | GABAPENTIN | 800MG | TABLET / ORAL | 2006-07-06 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A076877-001 | GABAPENTIN | 600MG | TABLET / ORAL | 2006-07-06 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A076877-002 | GABAPENTIN | 800MG | TABLET / ORAL | 2006-07-06 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A076877-001 | GABAPENTIN | 600MG | TABLET / ORAL | 2006-07-06 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A076877-002 | GABAPENTIN | 800MG | TABLET / ORAL | 2006-07-06 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A076877-001 | GABAPENTIN | 600MG | TABLET / ORAL | 2006-07-06 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A076877-002 | GABAPENTIN | 800MG | TABLET / ORAL | 2006-07-06 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A076877-001 | GABAPENTIN | 600MG | TABLET / ORAL | 2006-07-06 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A076877-002 | GABAPENTIN | 800MG | TABLET / ORAL | 2006-07-06 | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A076877-001 | GABAPENTIN | 600MG | TABLET / ORAL | 2006-07-06 | 03ed91905a0d… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A076877-002 | GABAPENTIN | 800MG | TABLET / ORAL | 2006-07-06 | 03ed91905a0d… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A076877-001 | GABAPENTIN | 600MG | TABLET / ORAL | 2006-07-06 | 2680178bc6a6… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A076877-002 | GABAPENTIN | 800MG | TABLET / ORAL | 2006-07-06 | 2680178bc6a6… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A076877-001 | GABAPENTIN | 600MG | TABLET / ORAL | 2006-07-06 | 5bbf6a4d5a75… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A076877-002 | GABAPENTIN | 800MG | TABLET / ORAL | 2006-07-06 | 5bbf6a4d5a75… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A076877-001 | GABAPENTIN | 600MG | TABLET / ORAL | 2006-07-06 | d8e5a09893c0… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A076877-002 | GABAPENTIN | 800MG | TABLET / ORAL | 2006-07-06 | d8e5a09893c0… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A076877-001 | GABAPENTIN | 600MG | TABLET / ORAL | 2006-07-06 | d06236e962d9… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A076877-002 | GABAPENTIN | 800MG | TABLET / ORAL | 2006-07-06 | d06236e962d9… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A076877-001 | GABAPENTIN | 600MG | TABLET / ORAL | 2006-07-06 | 79d66fd596c7… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A076877-002 | GABAPENTIN | 800MG | TABLET / ORAL | 2006-07-06 | 79d66fd596c7… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A076877-001 | GABAPENTIN | 600MG | TABLET / ORAL | 2006-07-06 | 301d65b070ca… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A076877-002 | GABAPENTIN | 800MG | TABLET / ORAL | 2006-07-06 | 301d65b070ca… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A076877-001 | GABAPENTIN | 600MG | TABLET / ORAL | 2006-07-06 | 1e350fbaab3a… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A076877-002 | GABAPENTIN | 800MG | TABLET / ORAL | 2006-07-06 | 1e350fbaab3a… | ||
| 2024-05-31 18:47 UTC | 2024-05 | A076877-001 | GABAPENTIN | 600MG | TABLET / ORAL | 2006-07-06 | 8072bd15b7f6… | ||
| 2024-05-31 18:47 UTC | 2024-05 | A076877-002 | GABAPENTIN | 800MG | TABLET / ORAL | 2006-07-06 | 8072bd15b7f6… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A076877-001 | GABAPENTIN | 600MG | TABLET / ORAL | 2006-07-06 | 5c6f7cd8ea54… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A076877-002 | GABAPENTIN | 800MG | TABLET / ORAL | 2006-07-06 | 5c6f7cd8ea54… | ||
| 2022-04-08 23:34 UTC | 2022-04 | A076877-001 | GABAPENTIN | 600MG | TABLET / ORAL | 2006-07-06 | 5d02ea3f76ae… | ||
| 2022-04-08 23:34 UTC | 2022-04 | A076877-002 | GABAPENTIN | 800MG | TABLET / ORAL | 2006-07-06 | 5d02ea3f76ae… | ||
| 2022-04-04 05:41 UTC | 2022-04 | A076877-001 | GABAPENTIN | 600MG | TABLET / ORAL | 2006-07-06 | 4b0b4de00fa7… | ||
| 2022-04-04 05:41 UTC | 2022-04 | A076877-002 | GABAPENTIN | 800MG | TABLET / ORAL | 2006-07-06 | 4b0b4de00fa7… | ||
| 2019-12-13 00:20 UTC | 2019-12 | A076877-001 | GABAPENTIN | 600MG | TABLET / ORAL | 2006-07-06 | 74a2ff9319b5… | ||
| 2019-12-13 00:20 UTC | 2019-12 | A076877-002 | GABAPENTIN | 800MG | TABLET / ORAL | 2006-07-06 | 74a2ff9319b5… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Gabapentin | GABAPENTIN | Proficient Rx LP | 9d401e54-d4f5-43ba-b898-dd08fc3c7bfa | 2026-07-01 | Warnings, Adverse reactions | Gabapentin GABAPENTIN |
| Gralise | GABAPENTIN | Almatica Pharma LLC | 466273b1-c9fc-3930-c94b-aa11394d5140 | 2026-06-30 | Warnings, Adverse reactions | GABAPENTIN |
| Gabapentin | GABAPENTIN | HAWAII REPACK, INC. | 14d61caa-17ce-4fa2-90fb-1470f3864be8 | 2026-06-26 | Warnings, Adverse reactions | Gabapentin GABAPENTIN |
| Gabapentin | GABAPENTIN | St. Mary's Medical Park Pharmacy | 2bc65375-77b8-1e50-e063-6294a90acf8f | 2026-06-26 | Warnings, Adverse reactions | Gabapentin GABAPENTIN |
| Gabapentin | GABAPENTIN | St. Mary's Medical Park Pharmacy | ba4d863d-be38-8cf5-e053-2995a90a69fb | 2026-06-26 | Warnings, Adverse reactions | Gabapentin GABAPENTIN |
| Gabapentin | GABAPENTIN | St. Mary's Medical Park Pharmacy | c85ae572-9893-629e-e053-2995a90a23fc | 2026-06-26 | Warnings, Adverse reactions | Gabapentin GABAPENTIN |
| Gabapentin | GABAPENTIN | Zhejiang Yongtai Pharmaceutical Co., Ltd | f1eda6cc-d9b2-4df4-a09b-20eebded760f | 2026-06-25 | Warnings, Adverse reactions | Gabapentin GABAPENTIN |
| Gabapentin | GABAPENTIN | Northwind Health Company, LLC | 552912b2-be59-0333-e063-6394a90a85c0 | 2026-06-25 | Warnings, Adverse reactions | Gabapentin GABAPENTIN |
| Gabapentin | GABAPENTIN | Northwind Health Company, LLC | 55292235-bf8f-46d0-e063-6294a90a91a5 | 2026-06-25 | Warnings, Adverse reactions | Gabapentin GABAPENTIN |
| Gabapentin | GABAPENTIN | Unit Dose Solutions, Inc. | 54ecc64b-f019-9fcb-e063-6294a90a00af | 2026-06-23 | Warnings, Adverse reactions | Gabapentin GABAPENTIN |
| Gabapentin | GABAPENTIN | Unit Dose Solutions, Inc. | 54edd6f3-06c7-a0c7-e063-6394a90a8b4f | 2026-06-23 | Warnings, Adverse reactions | Gabapentin GABAPENTIN |
| Gabapentin | GABAPENTIN | Teva Pharmaceuticals, Inc. | c7f21eaa-68ee-420c-9c98-e997cc73a297 | 2026-06-23 | Warnings, Adverse reactions | Gabapentin GABAPENTIN |
| Gabapentin | GABAPENTIN | Northwind Health Company, LLC | 1b44a3ab-4d06-205f-e063-6294a90af368 | 2026-06-22 | Warnings, Adverse reactions | Gabapentin GABAPENTIN |
| Gabapentin | GABAPENTIN | Unit Dose Solutions, Inc. | 54dc347e-cba0-ea73-e063-6294a90ab436 | 2026-06-22 | Warnings, Adverse reactions | Gabapentin GABAPENTIN |
| GABAPENTIN | GABAPENTIN | St. Mary's Medical Park Pharmacy | 235a6954-318a-9e3a-e063-6394a90a0e21 | 2026-06-19 | Warnings, Adverse reactions | GABAPENTIN GABAPENTIN |
| GABAPENTIN | GABAPENTIN | Bryant Ranch Prepack | c9f0cceb-b24e-4526-b873-fedd877d6bc6 | 2026-06-18 | Warnings, Adverse reactions | GABAPENTIN GABAPENTIN |
| GABAPENTIN | GABAPENTIN | Granules Pharmaceuticals Inc | c681c804-c6f3-d63b-e053-2995a90a6b8f | 2026-06-17 | Warnings, Adverse reactions | GABAPENTIN GABAPENTIN |
| Gabapentin | GABAPENTIN | Asclemed USA, Inc. | 9a829dc3-b2d8-4d19-a579-0597217cec9b | 2026-06-17 | Warnings, Adverse reactions | Gabapentin GABAPENTIN |
| Gabapentin | GABAPENTIN | Bryant Ranch Prepack | d8604417-9d43-4d27-a7ce-d4120ff201f4 | 2026-06-11 | Warnings, Adverse reactions | Gabapentin GABAPENTIN |
| Gabapentin | GABAPENTIN | St. Mary's Medical Park Pharmacy | b7a29b99-ce23-950e-e053-2995a90a1934 | 2026-06-09 | Warnings, Adverse reactions | Gabapentin GABAPENTIN |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.